[go: up one dir, main page]

AU7967294A - A monoclonal anti-human il-6 receptor antibody - Google Patents

A monoclonal anti-human il-6 receptor antibody

Info

Publication number
AU7967294A
AU7967294A AU79672/94A AU7967294A AU7967294A AU 7967294 A AU7967294 A AU 7967294A AU 79672/94 A AU79672/94 A AU 79672/94A AU 7967294 A AU7967294 A AU 7967294A AU 7967294 A AU7967294 A AU 7967294A
Authority
AU
Australia
Prior art keywords
human
monoclonal anti
receptor antibody
antibody
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79672/94A
Inventor
Ellen S. Vitetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU7967294A publication Critical patent/AU7967294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU79672/94A 1993-10-06 1994-10-06 A monoclonal anti-human il-6 receptor antibody Abandoned AU7967294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13261993A 1993-10-06 1993-10-06
US132619 1993-10-06
PCT/US1994/011305 WO1995009873A1 (en) 1993-10-06 1994-10-06 A monoclonal anti-human il-6 receptor antibody

Publications (1)

Publication Number Publication Date
AU7967294A true AU7967294A (en) 1995-05-01

Family

ID=22454859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79672/94A Abandoned AU7967294A (en) 1993-10-06 1994-10-06 A monoclonal anti-human il-6 receptor antibody

Country Status (2)

Country Link
AU (1) AU7967294A (en)
WO (1) WO1995009873A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10324639A (en) 1997-03-21 1998-12-08 Chugai Pharmaceut Co Ltd Preventing and therapeutic agent for disease associated with sensitized t cell containing il-6 antagonist as active ingredient
KR20090068385A (en) 1997-08-15 2009-06-26 츄가이 세이야꾸 가부시키가이샤 Preventive and / or therapeutic agent for systemic lupus erythematosus containing anti- interleukin-6 receptor antibody as an active ingredient
JP4124573B2 (en) 1998-03-17 2008-07-23 中外製薬株式会社 A prophylactic or therapeutic agent for inflammatory bowel disease comprising an IL-6 antagonist as an active ingredient
EP1334731B1 (en) 2000-10-25 2008-02-27 Chugai Seiyaku Kabushiki Kaisha Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
NZ541928A (en) 2003-02-24 2009-06-26 Chugai Pharmaceutical Co Ltd Remedy for spinal injury containing interleukin-6 antagonist
CA2542691C (en) 2003-10-17 2013-09-24 Chugai Seiyaku Kabushiki Kaisha Il-6 antagonist for use as mesothelioma therapeutic agent
AR048210A1 (en) 2003-12-19 2006-04-12 Chugai Pharmaceutical Co Ltd A PREVENTIVE AGENT FOR VASCULITIS.
EP1728801A4 (en) 2004-03-24 2009-10-21 Chugai Pharmaceutical Co Ltd Subtype of humanized antibody against interleukin-6 receptor
JP5014143B2 (en) 2005-10-14 2012-08-29 学校法人福岡大学 Inhibitor of transplanted islet injury in islet transplantation
WO2007046489A1 (en) 2005-10-21 2007-04-26 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for heart disease
AR057582A1 (en) 2005-11-15 2007-12-05 Nat Hospital Organization AGENTS TO DELETE INDUCTION OF CYTOTOXIC T LYMPHOCYTES
JPWO2007061029A1 (en) 2005-11-25 2009-05-07 学校法人慶應義塾 Prostate cancer treatment
WO2007086490A1 (en) 2006-01-27 2007-08-02 Keio University Remedy for disease associated with choroidal angiogenesis
CA2647846C (en) 2006-03-31 2016-06-21 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
US9260516B2 (en) 2006-04-07 2016-02-16 Osaka University Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor
US8080248B2 (en) 2006-06-02 2011-12-20 Regeneron Pharmaceuticals, Inc. Method of treating rheumatoid arthritis with an IL-6R antibody
PL2374818T3 (en) * 2006-06-02 2013-05-31 Regeneron Pharma High affinity antibodies to human IL-6 receptor
MX2009007830A (en) 2007-01-23 2009-10-07 Univ Shinshu Chronic rejection inhibitor.
JP5424330B2 (en) 2007-07-26 2014-02-26 国立大学法人大阪大学 A therapeutic agent for ocular inflammatory diseases comprising an interleukin 6 receptor inhibitor as an active ingredient
CN106519025B (en) 2007-09-26 2021-04-23 中外制药株式会社 Method for changing isoelectric point of antibody by using amino acid substitution of CDR
JP5264752B2 (en) 2007-10-02 2013-08-14 中外製薬株式会社 Graft-versus-host disease therapeutic agent comprising an interleukin 6 receptor inhibitor as an active ingredient
ES2564635T3 (en) 2008-05-13 2016-03-28 Novimmune Sa Anti-IL-6 / IL-6R antibodies and methods of use thereof
CA2728243C (en) 2008-06-05 2020-03-10 National Cancer Center Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer
JO3417B1 (en) 2010-01-08 2019-10-20 Regeneron Pharma Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
SI2578231T1 (en) 2010-05-28 2023-01-31 Chugai Seiyaku Kabushiki Kaisha Antitumor t cell response enhancer
TWI589299B (en) 2011-10-11 2017-07-01 再生元醫藥公司 Composition for treating rheumatoid arthritis and method of use thereof
US9017678B1 (en) 2014-07-15 2015-04-28 Kymab Limited Method of treating rheumatoid arthritis using antibody to IL6R
JP7185884B2 (en) 2017-05-02 2022-12-08 国立研究開発法人国立精神・神経医療研究センター METHOD FOR PREDICTING AND DETERMINING THERAPEUTIC EFFECT OF IL-6 AND NEUTROPHIL-RELATED DISEASE
WO2019078344A1 (en) 2017-10-20 2019-04-25 学校法人兵庫医科大学 Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
EP3917618A1 (en) 2019-01-31 2021-12-08 Sanofi Biotechnology Anti-il-6 receptor antibody for treating juvenile idiopathic arthritis
JP2022545312A (en) 2019-04-24 2022-10-27 サノフィ・バイオテクノロジー Methods of diagnosis and treatment of rheumatoid arthritis
MA56116A (en) 2019-06-04 2022-04-13 Stefano Fiore COMPOSITIONS AND METHODS FOR TREATING PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG42954A1 (en) * 1989-07-20 1997-10-17 Tadamitsu Kishimoto Antibody to human interleukin-6 receptor

Also Published As

Publication number Publication date
WO1995009873A1 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
AU7967294A (en) A monoclonal anti-human il-6 receptor antibody
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1289795A (en) Monoclonal antibodies specific for human interleukin-5
AU4618193A (en) Humanized antibodies
AU7863794A (en) Antihuman tyrosinase monoclonal antibody
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
EP0578515A3 (en) Humanized monoclonal antibodies.
EP0580859A4 (en) Anti-eda monoclonal antibody
AU3330689A (en) Monoclonal antibodies
IL100869A0 (en) Monoclonal ige receptor antibodies
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU5937598A (en) Humanized anti-human Fas antibody
AU6031090A (en) Monoclonal antibodies against a tumor-associated antigen
EP0506523A3 (en) Monoclonal antibodies
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
AU6725190A (en) Anti-platelet monoclonal antibody
GB9204928D0 (en) Monoclonal antibody production
AU1025692A (en) Novel chimeric antiidiotypic monoclonal antibodies
AU4719196A (en) Murine/human chimeric monoclonal antibody or a fragment thereof specific for the egf receptor
AU6059194A (en) Monoclonal antibodies to bovine cytokines
AU3079895A (en) Immunonanoparticles coated with anti-beta-2 microglobulin monoclonal antibodies
AU8547291A (en) Monoclonal antibodies against tenascin
EP0654532A4 (en) Antimucoglycoprotein monoclonal antibody.
AU2652897A (en) Anti-human mp52 monoclonal antibody